LASA SUPERGENERICS LTD (LASA) financials

LASA SUPERGENERICS LTD (LASA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.[1]

Market Cap: ₹25.8Cr.
Current Price: ₹5.16
ROE: -19.7%
ROCE: -18.2%
Book Value: ₹9.90
Dividend Yield: 0.00%
52W High / Low: ₹12.5/5.06

In Jun 2026, LASA SUPERGENERICS LTD (LASA) reported sales ₹1.23 Cr and net profit ₹-3.58 Cr.

Annual TTM: sales ₹6 Cr, net profit ₹-17 Cr.

Shareholding: Promoters 53.65% (Mar 2026), FIIs 0.00% (Mar 2026), Public 46.35% (Mar 2026), No. of Shareholders 27,702% (Mar 2026).

LASA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	39.39	33.08	39.14	20.01	3.06	2.20	-0.13	1.23
Expenses	38.60	32.81	35.73	20.51	7.06	2.95	1.99	2.62
Operating Profit	0.79	0.27	3.41	-0.50	-4.00	-0.75	-2.12	-1.39
OPM %	2.01%	0.82%	8.71%	-2.50%	-130.72%	-34.09%	—	-113.01%
Other Income	1.95	8.91	-21.52	-20.44	0.01	0.02	-0.42	-0.38
Interest	1.24	0.47	0.11	0.03	0.12	0.11	0.13	0.14
Depreciation	2.81	2.80	3.90	1.57	1.57	1.57	1.31	1.57
Profit before tax	-1.31	5.91	-22.12	-22.54	-5.68	-2.41	-3.98	-3.48
Tax %	146.56%	7.11%	-35.40%	-6.30%	10.04%	5.81%	4.77%	3.16%
Net Profit	-3.23	5.49	-14.29	-21.12	-6.25	-2.55	-4.16	-3.58
EPS in Rs	-0.64	1.10	-2.85	-4.22	-1.25	-0.51	-0.83	-0.71
Raw PDF	—	—	—	—	—	—	—	—

LASA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	167	201	137	130	104	142	25	6
Expenses	137	154	120	136	102	136	32	15
Operating Profit	30	47	16	-6	2	6	-7	-8
OPM %	18%	24%	12%	-4.9%	2.1%	4.5%	-29%	-130%
Other Income	0	0	-8	-18	-9	-11	-21	-1
Interest	8	2	0	4	2	3	0	0
Depreciation	17	16	15	13	11	12	6	6
Profit before tax	5	30	-6	-42	-19	-19	-35	-16
Tax %	23%	23%	-13%	-9%	14%	-24%	-2%	—
Net Profit	4	23	-5	-39	-22	-15	-34	-17
EPS in Rs	0.89	5.60	-1.31	-7.71	-4.34	-2.95	-6.80	-3.30
Dividend Payout %	-0%	4%	-24%	-0%	-0%	-0%	-0%	—

LASA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	23	41	41	50	50	50	50	50
Reserves	82	101	118	108	68	47	34	-0
Borrowings	85	48	19	20	22	22	2	10
Other Liabilities	69	42	29	31	24	32	16	7
Total Liabilities	258	232	208	209	164	151	102	67
Fixed Assets	162	152	143	137	119	110	68	55
CWIP	7	-0	-0	5	5	3	0	-0
Investments	-0	-0	-0	0	0	-0	-0	-0
Other Assets	90	80	65	67	40	39	33	12
Total Assets	258	232	208	209	164	151	102	67

LASA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	41	14	41	9	-17	2	-3	-8
Cash from Investing Activity	-7	-2	-4	-3	11	-0	8	0
Cash from Financing Activity	-33	-10	-36	-0	-4	-2	-6	7
Net Cash Flow	-0	2	1	6	-10	-0	-0	0
Free Cash Flow	29	13	35	12	-12	0	5	-7
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	397%	46%	87%	73%	273%	96%	-45%	105%

LASA shareholding pattern (%)
Category	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%	53.65%
FIIs	0.00%	0.01%	0.00%	0.00%	0.47%	0.00%	0.00%	0.00%
Public	46.34%	46.32%	46.35%	46.35%	45.88%	46.35%	46.34%	46.35%
No. of Shareholders	27,217	27,968	27,272	27,188	28,115	28,656	28,120	27,702

LASA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	62	45	27	50	7	13	4	1
Inventory Days	90	101	56	46	48	92	84	28
Days Payable	170	130	41	68	32	68	35	33
Cash Conversion Cycle	-18	16	42	28	22	37	53	-4
Working Capital Days	-52	-13	35	12	-17	-44	37	-102
ROCE %	-4%	7%	17%	1%	-12%	-6%	-1%	-18%

LASAUpdated 18 Oct 2026, 20:32

Lasa Supergenerics Ltd

LASAUpdated 18 Oct 2026, 20:32

Market Cap

₹25.8Cr.

Current Price

₹5.16

High / Low

₹12.5/5.06

ROE-19.7%

ROCE-18.2%

Book Value₹9.90

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	30.56	0.37	26.51	0	2.65	1.03	580.58	-4.95	-0.99
Sep 2023	24.3	0.56	23.25	0.08	2.68	-2.11	-99.05	-0.02	0
Dec 2023	26.66	0.44	25.6	0	2.68	-2.06	-29.61	-1.46	-0.29
Mar 2024	22.82	0.56	26.81	-8.76	2.66	-15.97	-4.2	-15.3	-3.05
Jun 2024	30.84	0.87	29.04	0	2.79	-1.86	46.77	-2.73	-0.54
Sep 2024	39.39	1.24	38.6	1.95	2.81	-1.31	146.56	-3.23	-0.64
Dec 2024	33.08	0.47	32.81	8.91	2.8	5.91	7.11	5.49	1.1
Mar 2025	39.14	0.11	35.73	-21.52	3.9	-22.12	-35.4	-14.29	-2.85
Jun 2025	20.01	0.03	20.51	-20.44	1.57	-22.54	-6.3	-21.12	-4.22
Sep 2025	3.06	0.12	7.06	0.01	1.57	-5.68	10.04	-6.25	-1.25
Dec 2025	2.2	0.11	2.95	0.02	1.57	-2.41	5.81	-2.55	-0.51
Mar 2026	-0.13	0.13	1.99	-0.42	1.31	-3.98	4.77	-4.16	-0.83
Jun 2026	1.23	0.14	2.62	-0.38	1.57	-3.48	3.16	-3.58	-0.71

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2016 1m	0	0	0	0	0	0	—	0	—
Mar 2017	199	12	153	-24	8	2	-10	2	—
Mar 2018	244	11	202	3	18	15	19	12	5.4
Mar 2019	170	8	158	0	19	-16	-25	-12	-5.26
Mar 2020	167	8	137	0	17	5	23	4	0.89
Mar 2021	201	2	154	0	16	30	23	23	5.6
Mar 2022	137	0	120	-8	15	-6	-13	-5	-1.31
Mar 2023	130	4	136	-18	13	-42	-9	-39	-7.71
Mar 2024	104	2	102	-9	11	-19	14	-22	-4.34
Mar 2025	142	3	136	-11	12	-19	-24	-15	-2.95
Mar 2026	25	0	32	-21	6	-35	-2	-34	-6.8
TTM	6	0	15	-1	6	-16	—	-17	-3.3

Shareholding pattern

As of Mar 2026%

Holder	Share
Promoters	53.65%
Public	46.35%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	Public
Jun 2023	53.65%	0%	46.34%
Sep 2023	53.65%	0%	46.34%
Dec 2023	53.65%	0.01%	46.33%
Mar 2024	53.65%	0.12%	46.23%
Jun 2024	53.65%	0%	46.34%
Sep 2024	53.65%	0.01%	46.32%
Dec 2024	53.65%	0%	46.35%
Mar 2025	53.65%	0%	46.35%
Jun 2025	53.65%	0.47%	45.88%
Sep 2025	53.65%	0%	46.35%
Dec 2025	53.65%	0%	46.34%
Mar 2026	53.65%	0%	46.35%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Other Assets	Total Assets
Mar 2016	0.05	0	0	0	0	0	0	0	0
Mar 2017	0.05	75	116	37	228	119	30	80	228
Mar 2018	23	94	107	63	287	170	7	110	287
Mar 2019	23	82	85	69	258	162	7	90	258
Mar 2020	41	101	48	42	232	152	0	80	232
Mar 2021	41	118	19	29	208	143	0	65	208
Mar 2022	50	108	20	31	209	137	5	67	209
Mar 2023	50	68	22	24	164	119	5	40	164
Mar 2024	50	47	22	32	151	110	3	39	151
Mar 2025	50	34	2	16	102	68	0	33	102
Mar 2026	50	0	10	7	67	55	0	12	67

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2016	0	0	0	0
Mar 2017	-3	0	0	-3
Mar 2018	40	-44	4	0
Mar 2019	41	-7	-33	0
Mar 2020	14	-2	-10	2
Mar 2021	41	-4	-36	1
Mar 2022	9	-3	0	6
Mar 2023	-17	11	-4	-10
Mar 2024	2	0	-2	0
Mar 2025	-3	8	-6	0
Mar 2026	-8	0	7	0

Key ratios

Historical financial ratios

Category	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	—	64	63	62	45	27	50	7	13	4	1
Inventory Days	—	93	90	90	101	56	46	48	92	84	28
Days Payable	—	71	102	170	130	41	68	32	68	35	33
Cash Conversion Cycle	—	87	51	-18	16	42	28	22	37	53	-4
Working Capital Days	—	15	-1	-52	-13	35	12	-17	-44	37	-102
ROCE %	—	42%	13%	-4%	7%	17%	1%	-12%	-6%	-1%	-18%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of LASA SUPERGENERICS LTD (LASA)?

The reported market capitalisation for LASA SUPERGENERICS LTD (LASA) is ₹25.8Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of LASA?

The current price shown for LASA SUPERGENERICS LTD (LASA) on Fincrux is ₹5.16 with a 52-week high/low of ₹12.5/5.06.

What were LASA latest quarterly results?

For Jun 2026, LASA SUPERGENERICS LTD (LASA) reported sales ₹1.23 Cr and net profit ₹-3.58 Cr (figures in ₹ crore unless noted).

What are LASA annual sales and net profit?

For TTM, LASA SUPERGENERICS LTD (LASA) shows sales of ₹6 Cr and net profit of ₹-17 Cr on the Fincrux profit & loss statement.

Who owns LASA SUPERGENERICS LTD (LASA)?

Latest shareholding for LASA SUPERGENERICS LTD (LASA) on Fincrux: Promoters 53.65% (Mar 2026), FIIs 0.00% (Mar 2026), Public 46.35% (Mar 2026), No. of Shareholders 27,702% (Mar 2026).

Where can I find LASA SUPERGENERICS LTD (LASA) financials?

LASA SUPERGENERICS LTD (LASA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show LASA balance sheet and cash flow?

Yes. The LASA SUPERGENERICS LTD (LASA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 October 2026 at 20:32